Report
AFYREN : Unsurprising H1 2024 results – pending continuous production at first plant
>H1 revenues of € 1.4m, down 30% / EBIT of -€ 3.6m - AFYREN’s H1 2024 results, reported yesterday evening, were broadly in line with our estimates. Revenues dropped by 30% to € 1.4m, with two constituent elements: i/ income from patent licences and ceded to AFYREN NEOXY since December 2018 for € 0.7m (stable) and ii/ service contracts with AFYREN NEOXY, also for € 0.7m (down as a result of the ramp-up of teams on site). Opex is stable (€ 5m), giving EBIT of -€ 3.6m. ...
Underlying
AFYREN
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Jeremy Garnier
Other Reports on these Companies
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.